BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15128773)

  • 1. Heart, but not skin, allografts from donors lacking Flt3 ligand exhibit markedly prolonged survival time.
    Wang Z; Castellaneta A; De Creus A; Shufesky WJ; Morelli AE; Thomson AW
    J Immunol; 2004 May; 172(10):5924-30. PubMed ID: 15128773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trafficking of APC from liver allografts of Flt3L-treated donors: augmentation of potent allostimulatory cells in recipient lymphoid tissue is associated with a switch from tolerance to rejection.
    Steptoe RJ; Li W; Fu F; O'Connell PJ; Thomson AW
    Transpl Immunol; 1999 Mar; 7(1):51-7. PubMed ID: 10375078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients.
    Fu F; Li Y; Qian S; Lu L; Chambers F; Starzl TE; Fung JJ; Thomson AW
    Transplantation; 1996 Sep; 62(5):659-65. PubMed ID: 8830833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
    Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
    J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
    Bonham CA; Peng L; Liang X; Chen Z; Wang L; Ma L; Hackstein H; Robbins PD; Thomson AW; Fung JJ; Qian S; Lu L
    J Immunol; 2002 Sep; 169(6):3382-91. PubMed ID: 12218160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential induction of Th1 responses by functionally mature hepatic (CD8alpha- and CD8alpha+) dendritic cells: association with conversion from liver transplant tolerance to acute rejection.
    Morelli AE; O'Connell PJ; Khanna A; Logar AJ; Lu L; Thomson AW
    Transplantation; 2000 Jun; 69(12):2647-57. PubMed ID: 10910289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig.
    Lan YY; Wang Z; Raimondi G; Wu W; Colvin BL; de Creus A; Thomson AW
    J Immunol; 2006 Nov; 177(9):5868-77. PubMed ID: 17056511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
    Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
    Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
    Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
    Transplantation; 2001 Oct; 72(8):1423-32. PubMed ID: 11685115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and functional characterization of mouse hepatic CD8 alpha+ lymphoid-related dendritic cells.
    O'Connell PJ; Morelli AE; Logar AJ; Thomson AW
    J Immunol; 2000 Jul; 165(2):795-803. PubMed ID: 10878353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival.
    Shen L; Jin Y; Freeman GJ; Sharpe AH; Dana MR
    J Immunol; 2007 Sep; 179(6):3672-9. PubMed ID: 17785803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hosts lacking fms-like tyrosine kinase 3 ligand exhibit marked reductions in transplant vascular sclerosis.
    Wang Z; Taner T; Morelli AE; Thomson AW
    Transplantation; 2005 Apr; 79(8):869-75. PubMed ID: 15849537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
    Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
    Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand.
    Daro E; Pulendran B; Brasel K; Teepe M; Pettit D; Lynch DH; Vremec D; Robb L; Shortman K; McKenna HJ; Maliszewski CR; Maraskovsky E
    J Immunol; 2000 Jul; 165(1):49-58. PubMed ID: 10861034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance.
    Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
    J Immunol; 2001 May; 166(9):5619-28. PubMed ID: 11313402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
    Mandelbrot DA; Furukawa Y; McAdam AJ; Alexander SI; Libby P; Mitchell RN; Sharpe AH
    J Immunol; 1999 Oct; 163(7):3753-7. PubMed ID: 10490971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.
    Hancock WW; Sayegh MH; Zheng XG; Peach R; Linsley PS; Turka LA
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13967-72. PubMed ID: 8943044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.